FindTrial
Sign In

Lumiracoxib

DRUG16 trials

Sponsors

Novartis, Novartis Pharmaceuticals, Hospital Central Sur de Pemex

Conditions

Acute Gouty ArthritisArthralgiaControlled HypertensionHealthy VolunteersKidney Failure, ChronicKnee OsteoarthritisMusculoskeletal PainOsteoarthritis

Phase 2

Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia
TerminatedNCT01481610
Hospital Central Sur de PemexArthralgia, Kidney Failure, Chronic
Start: 2012-01-31End: 2012-11-30Updated: 2013-02-13

Phase 3

52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine
CompletedNCT00145301
NovartisOsteoarthritis
Start: 2004-09-30Target: 3036Updated: 2012-05-21
6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis
CompletedNCT00170872
NovartisOsteoarthritis, Rheumatoid Arthritis
Start: 2004-11-30Target: 135Updated: 2012-05-21
Efficacy and Safety of Lumiracoxib
CompletedNCT00267215
NovartisOsteoarthritis
Start: 2000-11-30Target: 330Updated: 2012-05-21
Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).
CompletedNCT00366938
NovartisOsteoarthritis, Knee
Start: 2003-09-30Target: 1464Updated: 2012-05-21
Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)
CompletedNCT00367315
NovartisKnee Osteoarthritis
Start: 2003-09-30Target: 1684Updated: 2012-05-21
Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)
CompletedNCT00476034
NovartisOsteoarthritis
Start: 2003-12-31Updated: 2012-05-21
Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)
CompletedNCT00475800
NovartisOsteoarthritis
Start: 2004-01-31Updated: 2012-05-21
Safety of Lumiracoxib in Patients With Osteoarthritis
CompletedNCT00637949
NovartisOsteoarthritis
Start: 2000-12-31End: 2001-03-31Updated: 2008-03-18

Phase 4

Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain
CompletedNCT00170898
NovartisMusculoskeletal Pain
Start: 2004-11-30Target: 419Updated: 2006-10-13
Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout
CompletedNCT00170781
NovartisAcute Gouty Arthritis
Start: 2005-06-30Target: 234Updated: 2006-11-30
Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension
CompletedNCT00267176
Novartis PharmaceuticalsControlled Hypertension, Osteoarthritis
Start: 2005-11-30Target: 1020Updated: 2017-02-07
Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery
CompletedNCT00333567
NovartisPain
Start: 2006-08-31Target: 110Updated: 2007-12-13
Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib
CompletedNCT00348491
Novartis PharmaceuticalsPain
Start: 2006-02-28Target: 364Updated: 2017-02-23
Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel
CompletedNCT00350155
NovartisHealthy Volunteers
Start: 2006-05-31Target: 150Updated: 2007-12-13
Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension
CompletedNCT00419796
NovartisOsteoarthritis With Controlled Hypertension
Start: 2006-11-30End: 2007-09-30Target: 78Updated: 2007-11-29

Related Papers

A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
2008-09-086 citations
Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: a randomised controlled trial in patients with osteoarthritis.
2008-03-0717 citations